March 26, 2017


We feel like a SITTING DUCK on the markets.

“It’s waiting that helps you as an investor, and a lot of people just can’t stand to wait.” – Charlie Munger
HCM.L (ISIN: KYG4672N1016)

Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market.           

Market: AIM

Gain over the quarter: +32 % 

Fair value: £ 35.50
Discount: 18%
Average yearly return: 48%
Yield: N/A

Chi-Med: Continued Upside In 2017